Topics

Applied Therapeutics Inc. Company Profile

13:19 EDT 21st September 2019 | BioPortfolio

Applied Therapeutics is a privately held biotechnology company, focused on developing transformative drugs in areas of high unmet medical need – fatal or debilitating diseases for which no therapies are approved. The company applies cutting-edge technology to validated drug targets that have failed to produce meaningful therapies in the past. Applied Therapeutics believes that through innovative science, millions of lives can be saved. For more information, visit www.appliedtherapeutics.com.


News Articles [1158 Associated News Articles listed on BioPortfolio]

Applied Therapeutics files for IPO

Applied Therapeutics Inc. has filed for its initial public offering on the Nasdaq.

Applied Therapeutics Reports AT-007 SAD Data

Applied Therapeutics (NASDAQ:APLT) has announced it has finished the single ascending dose (SAD) healthy volunteer part of the Phase 1/2 study of AT-007 in galactosemia. As quoted in the press release...

Applied Therapeutics closes Series B round

Applied Therapeutics Inc. (cardiovascular and metabolic disease therapies) raised $25.1mm in its Series B financing to undisclosed investors.

Applied Therapeutics Starts Phase 1/2 Study of AT-007

Applied Therapeutics (NASAQ:APLT) has announced it has started its Phase 1/2 study of AT-007 in galactosemia. As quoted in the press release: The study, termed ACTION-Galactosemia, will investigate sa...

Applied Therapeutics Announces FDA Orphan Drug Designation for AT-007

Applied Therapeutics (NASDAQ:APLT) has announced that the US Food and Drug Administration (FDA) has granted the company orphan drug designation for AT-007 for late stages of preclinical development to...

FDA Grants Orphan Drug Designation to Applied Therapeutics AT-007 for Treatment of Galactosemia

NEW YORK, May 28, 2019 (GLOBE NEWSWIRE) — Applied Therapeutics Inc. (Nasdaq:APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated mol...

ASC Therapeutics unveils clotting factor data from gene therapy trial

ASC Therapeutics, a division of biotech firm Applied StemCell, unveiled data from animal studies in mice, primates and human  -More- 

Applied Therapeutics Begins U.S. IPO Effort

Drugs and Medications [163 Associated Drugs and Medications listed on BioPortfolio]

Kynamro [kastle therapeutics, llc]

NA

Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Epinephrine hypospray(r) [langford research institute]

Epinephrine HypoSpray

Ph7 gel mint [pascal company, inc.]

NA

Podocon 25 [paddock laboratories, llc]

Podocon-25® (25% podophyllin in benzoin tincture)

PubMed Articles [602 Associated PubMed Articles listed on BioPortfolio]

Discovery of novel fungal RiPP biosynthetic pathways and their application for the development of peptide therapeutics.

Bioactive peptide natural products are an important source of therapeutics. Prominent examples are the antibiotic penicillin and the immunosuppressant cyclosporine which are both produced by fungi and...

Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics.

There is mounting evidence supporting the use of biologic therapeutics for the management of noninfectious uveitis (NIU). This review highlights: biologics with documented efficacy in NIU; agents with...

Intravitreal nanoparticles for retinal delivery.

Teaser: Recent findings regarding utilization of intravitreally injected nanoparticles for the retinal-targeted delivery of all types of therapeutics are summarized. The respective pharmacokinetic mod...

CRISPR: a promising tool for lipid physiology and therapeutics.

The purpose is to review recent progress in applying the CRISPR/Cas9 system to lipid metabolism and therapeutics.

Ultra-rapid drug delivery in the oral cavity using ultrasound.

The delivery of therapeutics to the gastrointestinal (GI) mucosa remains primarily a function of diffusion and rapid delivery is a significant goal in drug delivery science. However, delivery is hinde...

Clinical Trials [1855 Associated Clinical Trials listed on BioPortfolio]

Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

The purpose of the study is to assess long-term side effects from subjects who receive a Fate Therapeutics genetically modified NK cell product. Subjects who previously took part in a Fate...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1785 Associated Companies listed on BioPortfolio]

Applied Therapeutics Inc.

Applied Therapeutics is a privately held biotechnology company, focused on developing transformative drugs in areas of high unmet medical need – fatal or debilitating disease...

Applied BioSciences Corp.

Applied BioSciences is a vertically integrated company focused on the development of science-driven cannabinoid therapeutics / biopharmaceuticals and delivering high-quality CBD products as well as s...

Applied DNA Sciences Inc.

Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production fo...

Journal of Applied Research

The Journal of Applied Research in Clinical and Experimental Therapeutics, a peer reviewed journal, is published by Therapeutic Solutions, LLC. Therapeutic Solutions, founded over the summer of 2000, ...

Applied NeuroSolutions, Inc.

Applied NeuroSolutions, Inc. (OTC BB:APSN - News) is developing diagnostics and therapeutics to detect and treat Alzheimer's disease (AD) building on discoveries originatin...

More Information about "Applied Therapeutics Inc." on BioPortfolio

We have published hundreds of Applied Therapeutics Inc. news stories on BioPortfolio along with dozens of Applied Therapeutics Inc. Clinical Trials and PubMed Articles about Applied Therapeutics Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Applied Therapeutics Inc. Companies in our database. You can also find out about relevant Applied Therapeutics Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record